ABBV - AbbVie Inc.
Close
178.92
-0.110 -0.061%
Share volume: 66,687
Last Updated: Thu 26 Dec 2024 08:29:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$179.03
-0.11
-0.06%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-04 | 2023-02-17 | 2023-05-05 | 2023-08-07 | 2023-11-06 | 2024-02-20 | 2024-05-03 | |
| Assets | |||||||||
| Total Assets | 143.186 B | 141.325 B | 138.805 B | 134.544 B | 135.367 B | 136.221 B | 134.711 B | 148.874 B | |
| Current Assets | 29.100 B | 30.364 B | 28.463 B | 26.488 B | 28.852 B | 33.224 B | 33.002 B | 38.871 B | |
| Inventories | 3.396 B | 3.172 B | 3.579 B | 3.833 B | 4.055 B | 3.981 B | 4.099 B | 4.245 B | |
| Other Current Assets | 4.506 B | 4.570 B | 4.401 B | 4.460 B | 4.540 B | 4.541 B | 4.932 B | 4.608 B | |
| Short Term Investments | 4.506 B | 4.570 B | 4.401 B | 4.460 B | 4.540 B | 4.541 B | 4.932 B | 4.608 B | |
| Total Receivables | 11.237 B | 10.743 B | 11.254 B | 11.473 B | 11.491 B | 11.412 B | 11.155 B | 11.949 B | |
| Current Cash | 9.961 B | 11.879 B | 9.229 B | 6.722 B | 8.766 B | 13.290 B | 12.816 B | 18.069 B | |
| Total Non-current Assets | 114.086 B | 110.961 B | 110.342 B | 108.056 B | 106.515 B | 102.997 B | 101.709 B | 110.003 B | |
| Property Plant Equipment | 4.958 B | 4.893 B | 4.935 B | 4.931 B | 4.943 B | 4.934 B | 4.989 B | 4.980 B | |
| Other Assets | 5.033 B | 5.382 B | 5.571 B | 5.800 B | 6.198 B | 7.094 B | 8.513 B | 9.067 B | |
| Intangible Assets | 71.823 B | 68.725 B | 67.439 B | 64.848 B | 62.862 B | 58.603 B | 55.610 B | 62.225 B | |
| Goodwill | 32.028 B | 31.726 B | 32.156 B | 32.220 B | 32.224 B | 32.091 B | 32.293 B | 33.426 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 143.186 B | 141.325 B | 138.805 B | 134.544 B | 135.367 B | 136.221 B | 134.711 B | 148.874 B | |
| Total liabilities | 128.533 B | 125.331 B | 121.551 B | 121.270 B | 122.501 B | 124.127 B | 124.351 B | 140.867 B | |
| Total current liabilities | 34.473 B | 32.712 B | 29.538 B | 27.590 B | 32.239 B | 34.773 B | 37.841 B | 41.522 B | |
| Accounts Payable | 0.000 | 0.000 | 2.934 B | 0.000 | 0.000 | 0.000 | 3.688 B | 0.000 | |
| Other liabilities | 30.768 B | 30.215 B | 30.655 B | 32.249 B | 32.294 B | 31.644 B | 32.327 B | 32.778 B | |
| Current long term debt | 11.930 B | 9.207 B | 4.136 B | 2.801 B | 5.203 B | 5.115 B | 7.191 B | 10.196 B | |
| Long term debt | 61.002 B | 60.399 B | 59.135 B | 59.292 B | 55.812 B | 55.631 B | 52.194 B | 63.805 B | |
| Other liabilities | 30.768 B | 30.215 B | 30.655 B | 32.249 B | 32.294 B | 31.644 B | 32.327 B | 32.778 B | |
| Minority interest | 35.000 M | 33.000 M | 33.000 M | 29.000 M | 32.000 M | 35.000 M | 37.000 M | 40.000 M | |
| Total Shareholder equity | 14.653 B | 15.994 B | 17.254 B | 13.274 B | 12.866 B | 12.094 B | 10.360 B | 8.007 B | |
| Common stock | 1.770 B | 1.771 B | 1.772 B | 1.770 B | 1.767 B | 1.767 B | 1.768 B | 1.769 B | |
| Retained earnings | 3.516 B | 4.953 B | 4.784 B | 2.393 B | 1.789 B | 933.000 M | -1.000 B | -2.384 B |